In What Could be a First, Drug Maker Gives Providers Deadline to Request 340B Overcharge Refunds

VistaPharm
Drug manufacturer VistaPharm says requests for refunds for 340B overcharges must be received before Aug. 31. No manufacturer is believed to have set such a deadline before, and it's unclear if VistaPharm is the first to say refunds are available upon request.
Generic and over-the-counter drug manufacturer VistaPharm said in a public notice this week that it has identified 340B covered entities [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

UPDATED: Contract Pharmacy Restrictions Cut $1.5 Billion in 340B Hospital Revenue, $8.4 Billion More Endangered, Report Says

340B Health study
Drug manufacturers' 340B contract pharmacy restrictions have pulled $8.4 billion out of the savings hospitals achieve using contract pharmacies to dispense 340B drugs, a new 340B Health study found.
Early, limited versions of contract pharmacy restrictions for 340B hospitals cut their revenue by $1.5 billion in one year, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Some 340B Hospitals Might Get Less Than Expected Under Fix for Illegal Medicare Drug Payment Cuts

Spreadsheet
CMS's projections of what it owes 340B hospitals for unlawful Medicare Part B drug payment cuts might not align with what health systems and hospitals expect to get.
A $9 billion Medicare proposal to repay 340B hospitals for unlawful Part B drug payment cuts includes a spreadsheet showing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers March to Capitol Hill for Second Straight Year to ‘Defend 340B’

CV340B
Around 50 340B provider advocates marched to the U.S. Capitol yesterday to urge Congress to defend the drug pricing program. Nonprofit group CV340B organized the demonstration.
On a sunny, humid, 92-degree afternoon in Washington, D.C., over 50 safety-net health care providers marched to the U.S. Capitol [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B PROVIDER LEADER SPOTLIGHT

Tiffany Taylor, Director of Compliance, Allies in Hope, Inc. and 2023 Scholarship Recipient for the Apexus Advanced 340B Operations Certificate Program

Tiffany Taylor

Q: Where did you go to college/graduate school?

I attended Southern Texas University, located in Houston, Texas. Go Tigers!

Q: Where do you live?

I currently live

Read More »

Adverse Appellate Rulings in Contract Pharmacy Cases Could Be “Truly Catastrophic,” 340B Health’s Testoni Says

Maureen Testoni
It could be “truly catastrophic” if two federal appeals courts rule as a third already has that drug makers do not have to deliver 340B drugs to multiple contract pharmacies, 340B Health President and CEO Maureen Testoni said at the 340B Coalition summer conference.
It could be “truly catastrophic” if two federal appeals courts rule as a third did in January that drug manufacturers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Celebrate 340B Medicare Drug Payment Fix, Object to How It’s Funded

Federal Register
CMS today formally published in the Federal Register its proposed remedy for illegal Medicare Part B drug payments cuts for many 340B hospitals from 2018 through 2022.
Provider groups widely celebrated the Medicare proposal to provide a $9 billion lump sum payment to reimburse 340B hospitals for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Ease 340B Requirements for Generic Drugs to Ease Shortages, Trade Group Tells Congressional Committee Chairs

Pills
Congress should ease 340B requirements for generic drugs to help stem shortages, the trade group for makers of the drugs said in a July 7 white paper.
Low-cost generic drugs should get an exemption from the 340B drug pricing program to help reduce drug shortages, the U.S. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Congress Weighs 340B Changes, Leading HIV/AIDS Group Urges it to Support the Program

Washington Examiner
Washington Examiner, a conservative news outlet, published an op-ed by AHF President Michael Weinstein urging Congress to protect 340B from the drug industry.
A leading not-for-profit HIV and AIDS treatment organization amplified its 340B advocacy recently with an op-ed in a Washington, D.C., [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live